For research use only. Not for human or veterinary use.Free Next Day UK Delivery on orders over £100
Analytically VerifiedVial of Retatrutide
← Back to Catalogue

Retatrutide

LY3437943 Reference Standard

£59.99 ex. VAT

12 researchers are currently viewing this protocol
High Demand: Only 25 vials remain in current verified batch
Select Dosage Format
Low Stock: Only 0 vials remaining in current synthesis batch

Dispatched on dry ice. Institutional PO accepted at checkout.

Verified Purity≥99% HPLC
Secure TransitTracked UK Delivery
ExpeditedSame-Day Dispatch
Certificate of Analysis

HPLC/MS Data Available

Print Certificate of Analysis →
Safety Data Sheet (SDS)

Handling and safety information

Request SDS →

Research Overview

A novel triple hormone receptor agonist targeting GLP-1, GIP, and Glucagon receptors, designed for investigating advanced metabolic pathways.

Pathways:GLP-1RGIPRGCGR

Scientific Specifications

CAS Number2381089-83-2
Molecular FormulaC221H342N46O68
Molecular Weight4731.3 g/molUnverified
SequenceY-{Aib}-QGTFTSDYS-I-{aMeL}-LDKK({AEEA}-{AEEA}-{gGlu}-1x-C20-fatty-acid)-A-Q-{Aib}-AFIEYLLEGGPSSGAPPPS-NH2
Chemical FormUnknown
AppearanceWhite lyophilised powder
SolubilitySoluble in Water/Bacteriostatic Water
Storage (Unopened)Store at -20°C (Lyophilised)
Handling Notes
  • Protect from light
  • Avoid repeated freeze-thaw cycles

Literature & Citations

Independent peer-reviewed literature investigating LY3437943. Purivo Biolabs supplies this compound strictly for in-vitro replication of these studies.

Clinical Literature & FAQ

Frequently Asked Questions

How should Retatrutide be stored?

Lyophilized Retatrutide is stable at room temperature for 90 days, but for long term storage it should be kept at -20°C. Upon reconstitution, it must be refrigerated at 2°C - 8°C and used within 30 days.

What is the typical purity of your reference standard?

Our minimum threshold is >99.0% by HPLC. Specific batch purity is detailed in the accompanying COA.

Research Use Only

This material is supplied strictly for in-vitro laboratory research. It is not for human or veterinary administration. Purivo Biolabs does not hold marketing authorisation and makes no therapeutic claims.